Skip to main content

Month: June 2020

PST vadovo pareigose D.Gesevičių keičia E.Urbonas

AB „Panevėžio statybos trestas“ (PST) direktorius Dalius Gesevičius abipusiu susitarimu palieka Bendrovę. Valdybos sprendimu, nuo birželio 23 d. generalinio direktoriaus pareigas perims Egidijus Urbonas, iki šiol vadovavęs PST grupės įmonėms UAB „Metalo meistrai“ ir UAB „Hustal“.Daugiau informacijos:Generalinis direktoriusDalius GesevičiusTel.: (8-45) 505 503

Continue reading

Cryptologic Announces Conversion of Outstanding Debentures

TORONTO, June 19, 2020 (GLOBE NEWSWIRE) — Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces the Company is providing notice to holders of its 8% extendible convertible unsecured debentures that the Company is completing the conversion (the “Conversion”) of all outstanding debentures into common shares (the “Common Shares”) of the Company at a conversion price of $1.00 (the “Conversion Price”), and that Cryptologic will provide for the payment of accrued interest to the date of Conversion by issuing Common Shares at a price equal to the accrued interest divided by the Conversion Price. The Company currently has 12,719,162 Common Shares issued and outstanding. An aggregate of 35,880,000 Common Shares will be issued as a result of the Conversion and payment of accrued interest in Common Shares.At a special...

Continue reading

MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales

Large shipment of 35,000 units of formulated finished products and bulk extract completed to MPL Australia to support commencement of sales revenueTORONTO, June 19, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its subsidiary, MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”) has entered into an agreement to supply pharmaceutical-quality (GMP certified), formulated cannabis oil products to Beacon Medical Australia Pty. Ltd. (“Beacon Medical Australia”), a subsidiary of VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (“VIVO Cannabis”).Under the agreement with Beacon Medical Australia, which has an initial...

Continue reading

Luckin Coffee Received Notification from Mr. Tianruo Pu of his Resignation as an Independent Director

BEIJING, June 19, 2020 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (the “Company”) (NASDAQ: LK) today announced the following:The Company received a letter of resignation dated June 16, 2020 from Mr. Tianruo Pu, under which Mr. Pu notified the Company of his resignation from the Board due to personal reasons, effective immediately. Following Mr. Pu’s resignation, both of the Audit Committee of the Board and the Special Committee of the Board consist of Mr. Sean Shao and Mr. Wai Yuen Chong, with Mr. Sean Shao serving as chairman.The Company thanks Mr. Pu for his dedicated service to the Company and is actively searching for suitable new independent director(s) to join the Board.Safe Harbor StatementThis announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These...

Continue reading

Mission Ready Announces a C$2.9MM Manufacturing Contract and a C$4.4MM Distribution Contract, Provides Corporate Update

VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) — Mission Ready Solutions Inc. (“Mission Ready” or the “Company”) (TSXV: MRS) is pleased to provide the following update related to new contract awards, the status of its Q1 2020 filings, and other corporate matters.C$2.9MM Manufacturing ContractThe Company is pleased to announce that it has received a C$2.9MM purchase order (“Purchase Order”) from a United States Small Business Administration 8(a) certified company (the “8A Partner”) to manufacture and supply specialized body armor systems for the United States Department of Defense.The Purchase Order follows the 2019 launch of a collaborative effort between Mission Ready and the 8A Partner, to design a modular, scalable, female-specific body armor (“FBA”) system tailored to meet the requirements of female military personnel....

Continue reading

36Kr Holdings Inc. Announces Changes to Board of Directors

BEIJING, June 19, 2020 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company” or “We”) (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced the appointment of Ms. Yang Li as a member of the Company’s Board of Directors (the “Board”), effective immediately. At the same time, Mr. Chao Zhu has stepped down from the Board due to personal reasons, effective June 17, 2020.Ms. Yang Li has served as the Company’s chief content officer since August 2019. Ms. Li is responsible for content creation for the Company’s platform and has extensive experience in the media sector. Prior to joining the Company, Ms. Li served at YiMagazine, previously known as CBNweekly which is sponsored by Shanghai Oriental Media Group, a leading business magazine in China, where...

Continue reading

Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process

BURLINGTON, Ontario, June 19, 2020 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has filed a non-provisional patent with the USPTO for an “Apparatus for and method of converting cbd and/or cbd derivatives to at least one other type of cannabinoid and/or cannabinoid derivative such as THC”. In conjunction with McMaster University and the team lead by Dr. James McNulty, RDT has discovered a new and efficient way to create THC from CBD. This selective method can generate delta 8 or delta 9 THC.Jason Lewis, RDT SVP and co-inventor said, “This is an incredible breakthrough for RDT and the industry as a whole. Our technology could revolutionize the way synthetic THC is...

Continue reading

Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31, 2020. Full versions of the Company’s unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com.“In the first quarter and year to date, the benefits of Emerald’s significant restructuring and cost-rationalization are strongly emerging. While these benefits were not fully realized in our Q1 financials, we can see our operational metrics and financial results clearly moving in the desired direction,” said Riaz Bandali, President and Chief Executive Officer of Emerald. “In not even two full quarters, our two newly launched and scaled-up cultivation facilities in BC and Quebec have been...

Continue reading

Teekay LNG Partners Declares Distributions on Series A and B Preferred Units

HAMILTON, Bermuda, June 19, 2020 (GLOBE NEWSWIRE) — Teekay GP LLC, the general partner of Teekay LNG Partners L.P. (Teekay LNG or the Partnership) (NYSE:TGP), has declared cash distributions of $0.5625 per unit on the Partnership’s Series A preferred units (NYSE:TGP PR A) and $0.5313 per unit on the Partnership’s Series B preferred units (NYSE:TGP PR B) for the period from April 1, 2020 to June 30, 2020. The cash distributions are payable on July 15, 2020 to all unitholders of record as at June 30, 2020. Teekay LNG’s preferred unit distributions are reported on Form 1099 for United States tax purposes.About Teekay LNGTeekay LNG is one of the world’s largest independent owners and operators of LNG carriers, providing LNG and LPG services primarily under long-term, fee-based charter contracts through its interests in 47 LNG carriers,...

Continue reading

Low Speed Vehicle Market to Reach USD 8.17 Billion by 2026; Increasing Emphasis on Adoption of Environment-friendly Vehicles Will Aid Growth, says Fortune Business Insights™

Pune, June 19, 2020 (GLOBE NEWSWIRE) — The global low speed vehicle market size is projected to reach USD 8.17 billion by the end of 2026. Applications of the product across diverse industry verticals will aid the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Low Speed Vehicle Market Size, Share & Industry Analysis, By Engine Type (ICE, Electric), By Vehicle Type (Industrial Utility, Golf Cart, Personal Carrier, Public Transport Vehicle), and Regional Forecasts, 2019-2026,” the market was worth USD 5.65 billion in 2018 and will exhibit a CAGR of 4.8% during the forecast period, 2019-2026.Browse Summary of this Research Report with Detailed Table of Content: https://www.fortunebusinessinsights.com/low-speed-vehicle-market-103021 COVID-19 Impact Analysis:The recent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.